Michael Dong

Westchester Medical Center

Papers

1

Total Citations

59

H-Index

1

About

Michael Dong is a leading figure in the field of hepatopancreatobiliary (HPB) surgery, with a focused expertise in the comparative effectiveness of robotic versus open surgical techniques. His major contributions center on demonstrating that minimally invasive approaches, particularly robotic pancreaticoduodenectomy, can yield superior histopathological outcomes compared to traditional open surgery. In his landmark 2021 meta-analysis, which has garnered 59 citations, Dong systematically reviewed data from major databases to show that robotic procedures achieve significantly higher rates of negative resection margins—a critical factor in improving long-term oncologic outcomes. This work has helped shift the paradigm in pancreatic cancer surgery, providing robust evidence that robotic techniques not only reduce postoperative morbidity but also enhance the quality of cancer clearance. Dong’s research is widely cited by surgeons and oncologists seeking to optimize surgical strategies, and his findings have been instrumental in guiding clinical guidelines for minimally invasive pancreatic resections. His ongoing work continues to refine surgical protocols, cementing his reputation as a key contributor to evidence-based HPB surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
59
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
Robotic pancreaticoduodenectomy provides better histopathological outcomes as compared to its open counterpart: a meta-analysis
59 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Westchester Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago